Answers are grounded in this paper and cite their sources.
Randomized trial demonstrates enhanced cognitive and balance recovery with cerebellar tDCS in stroke patients, highlighting a targeted neuromodulatory rehabilitation approach.
Motor and cognitive dysfunctions are the most prevalent functional impairments in patients with stroke. The cerebellum is involved in regulating cognitive and motor functions in the human body, but the impact of cerebellar transcranial direct current stimulation (tDCS) on cognitive and motor functions in patients with stroke is currently unclear. This study aimed to evaluate the efficacy of cerebellar tDCS on cognitive and motor dysfunctions in patients with stroke. This randomized, single-blind, sham-controlled prospective study recruited patients with cerebral hemisphere stroke who had cognitive and motor deficits between November, 2018 and November, 2020. Participants were allocated into active tDCS (A-tDCS) or sham (S-tDCS) group. Both groups received standardized rehabilitation therapy and cognitive training along with cerebellar active tDCS or sham tDCS for 20 min, once a day, 5 days a week with 4-week treatments. Primary outcomes were the change from baseline to 4 weeks after randomization in the Montreal Cognitive Assessment (MoCA) and Berg Balance Scale (BBS). The clinically meaningful response rates in MoCA and BBS score, as well as score changes in Fugl-Meyer Assessment Scale for Lower Extremities (FMA-LE) and Barthel Index (BI) were also assessed. A total of 74 eligible participants (mean [SD] age, 56.4 [13.2] years; 16 female [21.6%]) were randomly assigned to A-tDCS (n = 37) or S-tDCS (n = 37) group and included in intention-to-treat analysis. At 4 weeks after randomization, compared to S-tDCS group, A-tDCS group showed significant higher MoCA score changes (6.78 [95% CI, 5.77–7.8] vs. 5.05 [4.03–6.08]; mean difference [95% CI], 1.73 [0.36–3.10]; P = 0.004) and BBS score changes (17.30 [13.59-21.00] vs. 11.86 [7.86–15.87]; 5.43 [0.23–10.64]; P = 0.037). In A-tDCS group, the clinically meaningful response rates in MoCA (78.4% vs. 54.1%; odds ratio [95% CI], 3.08 [1.12–8.50]; P = 0.015) and BBS (78.4% vs. 48.6%; 3.90 [1.37–11.09]; P = 0.011) scores were higher. The FMA-LE score changes showed no significant difference between the groups at 4 weeks after randomization (6.97 [5.13–8.81] vs. 6.57 [4.67–8.47]; 0.41 [-2.12-2.93]; P = 0.517). However, at 12 weeks after randomization, the FMA-LE score changes in the A-tDCS group were significantly higher than those in the S-tDCS group (12.03 [9.29–14.77] vs. 8.62 [6.40-10.84]; 3.41 [0.04–6.77]; P = 0.023). Four weeks of cerebellar tDCS in this trail improved cognitive and balance dysfunction after stroke. However, the improvement in lower limb motor function of hemiplegic patients was not significant, and only positive effects were observed during follow-up. These findings may present a novel targeted neuromodulation approach with potential for dual-domain functional enhancement in post-stroke rehabilitation. Registry Chictr.org.cn, ChiCTR2200061838, Registration date: 3 July 2022.
No takes yet. Share an insight, caveat, or question.
龚秋纹 et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: